Celecoxib 200 mg Capsule PCD Franchise in Mumbai

Pain Relief Medicine Distributor in Delhi NCR

COX-2 Inhibitor Capsules Supplier in Chennai

Ortho Segment PCD Pharma in Kolkata

Celecoxib Capsules Stockist in Bangalore
Anti-Inflammatory Products Exporter in Hyderabad

Home/Products /celecoxib-200mg-capsule

Celecrib 200 Capsule

Composition : Celecoxib (200mg) Capsule

Dosage Form : Capsule

Packaging Type : Blister

Packaging : 10*10

Price : ₹249/-

Celecrib 200 Capsule contains Celecoxib 200 mg, a selective COX-2 inhibitor widely used for the management of pain, inflammation, and stiffness associated with arthritis, musculoskeletal disorders, and acute pain conditions.

Celecoxib offers effective anti-inflammatory action while minimizing gastrointestinal side effects compared to traditional NSAIDs, making it a preferred therapy in long-term orthopedic and rheumatology care.

The 200 mg strength provides sustained relief, helping improve mobility and comfort in patients dealing with chronic joint pain, osteoarthritis, rheumatoid arthritis, and postoperative pain management.

Categorized under the orthopedic, pain management, and anti-inflammatory segment, Celecrib 200 Capsule is a high-demand product in clinics, hospitals, and orthopedic practice setups. For PCD pharma franchise partners, wholesalers, and third-party manufacturers, this product offers excellent market potential due to consistent prescriptions and wide therapeutic usage.

Read More

About the Product

Celecrib 200 Capsule contains Celecoxib 200 mg, a selective COX-2 inhibitor widely used for the management of pain, inflammation, and stiffness associated with arthritis, musculoskeletal disorders, and acute pain conditions.

Celecoxib offers effective anti-inflammatory action while minimizing gastrointestinal side effects compared to traditional NSAIDs, making it a preferred therapy in long-term orthopedic and rheumatology care.

The 200 mg strength provides sustained relief, helping improve mobility and comfort in patients dealing with chronic joint pain, osteoarthritis, rheumatoid arthritis, and postoperative pain management.

Categorized under the orthopedic, pain management, and anti-inflammatory segment, Celecrib 200 Capsule is a high-demand product in clinics, hospitals, and orthopedic practice setups. For PCD pharma franchise partners, wholesalers, and third-party manufacturers, this product offers excellent market potential due to consistent prescriptions and wide therapeutic usage.

Common side effects may include stomach discomfort, indigestion, gas, headache, dizziness, or swelling in the legs. Rarely, serious effects like increased blood pressure, kidney issues, or heart-related events may occur. Seek medical advice if you experience chest pain, severe stomach pain, or breathing difficulty.

Celecrib 200 Capsule is indicated for the management of pain and inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain, and menstrual cramps (dysmenorrhea).

Take Celecrib 200 Capsule exactly as prescribed, preferably with food to reduce stomach discomfort. Inform your doctor if you have a history of heart disease, hypertension, kidney problems, or stomach ulcers. Avoid alcohol and do not exceed the recommended dose.

Store Celecrib 200 Capsule in a cool, dry place below 25°C, away from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation